Corporate News     04-May-22
Biocon Biologics' new mAbs drug substance facility undergoes HPRA's GMP inspection
Biocon announced that the Health Products Regulatory Authority (HPRA), Ireland, conducted a GMP inspection of one of Biocon Biologics' new monoclonal antibody drug substance manufacturing facilities in Biocon Park, Bengaluru, India, between 28 March and 01 April 2022.

The inspection report contains no ‘critical' observations and only one of the deficiencies is categorized as ‘major' which is being addressed expeditiously in consultation with the regulatory agency

Previous News
  Biocon consolidated net profit declines 56.74% in the March 2024 quarter
 ( Results - Announcements 16-May-24   18:25 )
  Biocon PAT slides 57% to Rs 136 crore in Q4 FY24
 ( Hot Pursuit - 17-May-24   10:37 )
  Biocon's subsidiary receives UK’s MHRA approval for Aflibercept biosimilar
 ( Hot Pursuit - 13-Nov-23   17:05 )
  Biocon records turnaround PAT of Rs 660 cr in Q3
 ( Hot Pursuit - 09-Feb-24   14:12 )
  Biocon Ltd spurts 1.83%, gains for third straight session
 ( Hot Pursuit - 22-Mar-24   13:05 )
  Biocon Biologics partners with Sandoz AG
 ( Corporate News - 09-Feb-24   09:15 )
  Biocon receives Complete Response Letter for Biologics License Application
 ( Corporate News - 09-Feb-24   09:11 )
  Board of Biocon appoints director
 ( Corporate News - 27-Jul-23   12:46 )
  Biocon to declare Quarterly Result
 ( Corporate News - 10-Oct-23   11:29 )
  Biocon redeems commercial papers worth Rs 2,250 crore
 ( Hot Pursuit - 23-Feb-23   11:50 )
  Biocon Ltd spurts 2.7%, up for third straight session
 ( Hot Pursuit - 05-Apr-23   13:05 )
Other Stories
  Stanpacks (India) schedules AGM
  13-Jul-24   17:34
  Steelcast schedules AGM
  13-Jul-24   17:33
  Motisons Jewellers to table results
  13-Jul-24   17:33
  Bimetal Bearings to conduct board meeting
  13-Jul-24   17:33
  Next Mediaworks schedules board meeting
  13-Jul-24   17:33
  Deep Industries secures LoA for charter hiring worth Rs 82 cr
  13-Jul-24   15:51
  Board of Geojit Financial Services appoints Chairman and MD
  13-Jul-24   15:50
  Board of Geojit Financial Services approves rights issue of Rs 200 cr
  13-Jul-24   15:48
  Arihant Superstructures announces resignation of company secretary
  13-Jul-24   15:46
  Board of Coral Laboratories recommends Final Dividend
  13-Jul-24   15:18
Back Top